ADHD Generic Drug Recalled Following Laboratory Test Failure
The generic medication lisdexamfetamine, commonly known as the generic version of Vyvanse, is currently under a nationwide recall. This recall affects several lots of the drug, which is widely used to treat attention deficit hyperactivity disorder (ADHD) in both children and adults. The recall was initiated by Sun Pharmaceutical Industries due to a laboratory test failure that indicated the capsules did not dissolve as intended.
Details of the Recall
The U.S. Food and Drug Administration (FDA) announced that the inadequate dissolution of the affected capsules could lead to patients not receiving the required therapeutic dose. This may result in a lack of the full beneficial effects of the medication, posing a significant health risk for those relying on it for ADHD management.
Affected Product Information
The recall includes numerous lot numbers of the medication, packaged in 100-count bottles. Below are specifics about the recalled lots:
- 10 mg Capsules:
- NDC: 57664-046-88, Lot: AD42468, Expiration Date: 2/28/2026
- NDC: 57664-046-88, Lot: AD48705, Expiration Date: 4/30/2026
- 20 mg Capsules:
- NDC: 57664-047-88, Lot: AD42469, Expiration Date: 2/28/2026
- NDC: 57664-047-88, Lot: AD48707, Expiration Date: 4/30/2026
- 30 mg Capsules:
- NDC: 57664-048-88, Lot: AD42470, Expiration Date: 2/28/2026
- NDC: 57664-048-88, Lot: AD48708, Expiration Date: 4/30/2026
- 40 mg Capsules:
- NDC: 57664-049-88, Lot: AD48709, Expiration Date: 4/30/2026
- NDC: 57664-049-88, Lot: AD50894, Expiration Date: 5/31/2026
- 50 mg Capsules:
- NDC: 57664-050-88, Lot: AD48710, Expiration Date: 4/30/2026
- NDC: 57664-050-88, Lot: AD50895, Expiration Date: 5/31/2026
- 60 mg Capsules:
- NDC: 57664-051-88, Lot: AD48711, Expiration Date: 4/30/2026
- NDC: 57664-051-88, Lot: AD50896, Expiration Date: 5/31/2026
- 70 mg Capsules:
- NDC: 57664-052-88, Lot: AD48712, Expiration Date: 4/30/2026
- NDC: 57664-052-88, Lot: AD50898, Expiration Date: 5/31/2026
What Patients Should Do
Patients using lisdexamfetamine should check their medication for the listed lot numbers. If your medication is affected, consult your pharmacy for guidance on how to proceed. It is crucial for patients to ensure they are receiving the correct dosage to manage their ADHD effectively.
Staying informed about medication recalls is vital for patient safety. Regularly check official resources or pharmacy updates regarding your medications to ensure their efficacy and safety.
